
|Videos|May 12, 2016
Specialty Pharmacy and the Rise of Value-Based Care
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.
Advertisement
Marc O'Connor, chief operating officer of Curant Health, discusses how the transition to value-based care can be optimized for specialty stakeholders.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
FDA, HHS Move to Accelerate Biosimilar Approvals
3
Accelerated Approval of Cancer Drugs: Benefit or Burden?
4
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
5

















































































































































































































